Trials / Completed
CompletedNCT01284309
A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
A Phase 1b, Randomized, Double-Masked, Parallel Group, Placebo Controlled Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 321 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the affect of mirabegron on intraocular pressure (IOP) in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2011-01-27
- Last updated
- 2013-12-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01284309. Inclusion in this directory is not an endorsement.